Why in news?
The Department of Biotechnology celebrated its 40th Foundation Day by launching the SUJVIKA portal, a new platform that uses artificial intelligence to analyse India’s biotechnology imports. The portal identifies high‑value imported products that could be manufactured domestically, helping the country reduce its dependence on foreign suppliers. It comes at a time when the government is aiming for a US $1 trillion bioeconomy by 2047.
Background
The Department of Biotechnology (DBT) was established in 1986 to promote research and innovation in biological sciences. Over the decades it has funded laboratories, universities and startups, contributing to vaccines, genetic engineering and bio‑fuels. Recognising that India still imports many advanced biotech products, the DBT developed an AI‑based tool to sift through import data and pinpoint opportunities for local production.
What SUJVIKA does
- Automated data analysis: The portal uses AI and machine learning algorithms to organise import data across sectors like biopharmaceuticals, industrial enzymes and diagnostics.
- Sector‑wise insights: It generates dashboards highlighting which biotech products account for the highest import costs. This helps policymakers and industry leaders prioritise areas for indigenisation.
- Guiding investment: By identifying high‑value imports that could be produced in India, the portal guides public and private investments into domestic manufacturing.
- Accessible platform: Registered users can access detailed reports, filter data and visualise trends, making the portal a tool for researchers, entrepreneurs and government agencies.
Significance
- The portal supports India’s ambition to build a robust bioeconomy by reducing dependence on foreign biotechnology products.
- It fosters Atmanirbhar Bharat (self‑reliant India) by showing where indigenous innovation can replace imports.
- Better data may encourage investors to fund startups and industries that manufacture critical biotech components locally.
- The platform’s AI‑driven approach reflects the government’s emphasis on digital and data‑enabled governance.
Conclusion
SUJVIKA is not just a database; it is a strategic tool for charting India’s biotech future. By highlighting gaps in domestic manufacturing and offering actionable insights, it can help policymakers and entrepreneurs make informed decisions that strengthen the nation’s bioeconomy.
Source: Press Information Bureau
